We have been studying anticancer effect of Maitake D-fraction (PDF), isolated from maitake mushroom, on various cancer cells in the past 24 years. PDF was highly effective on those cells, profoundly reducing their cell viability. However, we have not yet examined PDF on other cancer cells, particularly pancreatic, cervical, and small-cell lung cancer cells, which had been known to be dismal and deadly. Hence, we investigated if PDF alone or its combination with vitamin C (VC) might have a significant anticancer effect against those cancer cells. Pancreatic cancer AsPC-1, cervical cancer HT-3, and small-cell lung cancer H69AR cells, were treated with PDF or the combination of PDF and VC for 72 or 96 h and cell viability was determined to assess anticancer effect. The potential anticancer mechanism was also explored, focusing on glycolysis, chromatin structure, and apoptosis. A dose-dependent study showed that ≥30 μg/ml, ≥50 μg/ml, and ≥50 μg/ml of PDF led to the significant reduction in cell viability of AsPC-1, HT-3, and H69AR cells, respectively – the greater cell viability reduction is indicative of the greater anticancer effect. When these cancer cells were treated with the combination of PDF and VC with their ineffective/negligeable concentrations, their cell viability was more profoundly reduced , demonstrating a synergistic potentiation. Moreover, such a potentiation was primarily associated with increased oxidative stress (OXS), glycolysis inhibition, chromatin modifications, and ultimate apoptosis. In conclusion, the present study demonstrates anticancer effect of PDF and its synergistic potentiation with VC against AsPC-1, HT-3, and H69AR cells. Particularly, the enhancement of anticancer effect with the PDF/VC combination is rather extraordinary, accompanied by alterations in the essential cellular events. Therefore, PDF alone or its combination with VC may have some clinical implications in patients with various cancers.
KeywordsMaitake D-FractionPDFVitamin CAnticancerPancreatic CancerCervical CancerSmall-Cell Lung Cancer
Mizuno, T. and Zhuang, C. (1995) Maitake, Grifola frondosa : Pharmacological Effects. Food Reviews International , 11, 135-149. https://doi.org/10.1080/87559129509541024
Konno, S. (2009) Synergistic Potentiation of D-Fraction with Vitamin C as Possible Alternative Approach for Cancer Therapy. International Journal of General Medicine , 2, 91-108. https://doi.org/10.2147/ijgm.s5498
Siegel, R.L., Giaquinto, A.N. and Jemal, A. (2024) Cancer Statistics, 2024. CA : A Cancer Journal for Clinicians , 74, 12-49. https://doi.org/10.3322/caac.21820
Gillen, S., Schuster, T., Meyer zum Büschenfelde, C., Friess, H. and Kleeff, J. (2010) Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Response and Resection Percentages. PLOS Medicine , 7, e1000267. https://doi.org/10.1371/journal.pmed.1000267
Yue, Q., Gao, G., Zou, G., Yu, H. and Zheng, X. (2017) Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements. BioMed Research International , 2017, Article 8412508. https://doi.org/10.1155/2017/8412508
Nahand, J.S., Taghizadeh‐boroujeni, S., Karimzadeh, M., Borran, S., Pourhanifeh, M.H., Moghoofei, M., et al . (2019) microRNAS: New Prognostic, Diagnostic, and Therapeutic Biomarkers in Cervical Cancer. Journal of Cellular Physiology , 234, 17064-17099. https://doi.org/10.1002/jcp.28457
Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J.L.M. and Shah, K.V. (2002) The Causal Relation between Human Papillomavirus and Cervical Cancer. Journal of Clinical Pathology , 55, 244-265. https://doi.org/10.1136/jcp.55.4.244
Mirzaei, H., Mirzaei, H., Sahebkar, A., Salehi, R., Nahand, J., Karimi, E., et al . (2016) Boron Neutron Capture Therapy: Moving toward Targeted Cancer Therapy. Journal of Cancer Research and Therapeutics , 12, 520-525. https://doi.org/10.4103/0973-1482.176167
Vora, C. and Gupta, S. (2018) Targeted Therapy in Cervical Cancer. ESMO Open , 3, e000462. https://doi.org/10.1136/esmoopen-2018-000462
Chaichian, S., Moazzami, B., Sadoughi, F., Haddad Kashani, H., Zaroudi, M. and Asemi, Z. (2020) Functional Activities of Beta-Glucans in the Prevention or Treatment of Cervical Cancer. Journal of Ovarian Research , 13, Article No. 24. https://doi.org/10.1186/s13048-020-00626-7
Zhang, L., Li, H., Zhang, F., Wang, S. and Li, G. (2020) CAR-T Immunotherapy and Non-Small Cell Lung Cancer: Bottleneck and Dawn. Chinese Journal of Lung Cancer , 23, 916-920.
Tandberg, D.J., Tong, B.C., Ackerson, B.G. and Kelsey, C.R. (2017) Surgery versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Comprehensive Review. Cancer , 124, 667-678. https://doi.org/10.1002/cncr.31196
Konno, S., Alexander, B., Freilich, D. and Choudhury, M. (2013) Improved Anticancer Effects on Various Cancers with Combinations of Chemotherapeutic Drugs or Vitamin C and D-Fraction. Journal of Cancer Therapy , 4, 843-850. https://doi.org/10.4236/jct.2013.44096
Megyesfalvi, Z., Gay, C.M., Popper, H., Pirker, R., Ostoros, G., Heeke, S., et al . (2023) Clinical Insights into Small Cell Lung Cancer: Tumor Heterogeneity, Diagnosis, Therapy, and Future Directions. CA : A Cancer Journal for Clinicians , 73, 620-652. https://doi.org/10.3322/caac.21785
Dargel, R. (1992) Lipid Peroxidation—A Common Pathogenetic Mechanism? Experimental and Toxicologic Pathology , 44, 169-181. https://doi.org/10.1016/s0940-2993(11)80202-2
Morishige, F., Nakamura, T., Nakamura, N. and Morishige, N. (1986) The Role of Vitamin C in Tumor Therapy (Human). In: Meyskens, F.L. and Prasad, K.N., Eds., Vitamins and Cancer , Humana Press, 399-427. https://doi.org/10.1007/978-1-4612-5006-7_26
Pelicano, H., Martin, D.S., Xu, R. and Huang, P. (2006) Glycolysis Inhibition for Anticancer Treatment. Oncogene , 25, 4633-4646. https://doi.org/10.1038/sj.onc.1209597
Liu, Q., Chen, X., Tan, Y., Liu, J., Zhu, M., Li, D., et al . (2024) Natural Products as Glycolytic Inhibitors for Cervical Cancer Treatment: A Comprehensive Review. Biomedicine & Pharmacotherapy , 175, Article 116708. https://doi.org/10.1016/j.biopha.2024.116708
Miccoli, L., Oudard, S., Sureau, F., Poirson, F., Dutrillaux, B. and Poupon, M. (1996) Intracellular pH Governs the Subcellular Distribution of Hexokinase in a Glioma Cell Line. Biochemical Journal , 313, 957-962. https://doi.org/10.1042/bj3130957
Kreuz, S. and Fischle, W. (2016) Oxidative Stress Signaling to Chromatin in Health and Disease. Epigenomics , 8, 843-862. https://doi.org/10.2217/epi-2016-0002
Gao, Y. and Tollefsbol, T.O. (2018) Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic-Mediating Machinery. International Journal of Molecular Sciences , 19, Article 2204. https://doi.org/10.3390/ijms19082204
Noh, S., Choi, E., Hwang, C., Jung, J.H., Kim, S. and Kim, B. (2019) Dietary Compounds for Targeting Prostate Cancer. Nutrients , 11, Article 2401. https://doi.org/10.3390/nu11102401
Lowe, S.W. and Lin, A.W. (2000) Apoptosis in Cancer. Carcinogenesis , 21, 485-495. https://doi.org/10.1093/carcin/21.3.485
Fiandalo, M.V. and Kyprianou, N. (2012) Caspase Control: Protagonists of Cancer Cell Apoptosis. Experimental Oncology , 34, 165-175.
Pop, C. and Salvesen, G.S. (2009) Human Caspases: Activation, Specificity, and Regulation. Journal of Biological Chemistry , 284, 21777-21781. https://doi.org/10.1074/jbc.r800084200
Boulares, A.H., Yakovlev, A.G., Ivanova, V., Stoica, B.A., Wang, G., Iyer, S., et al . (1999) Role of Poly(ADP-Ribose) Polymerase (PARP) Cleavage in Apoptosis. Journal of Biological Chemistry , 274, 22932-22940. https://doi.org/10.1074/jbc.274.33.22932
Mashimo, M., Onishi, M., Uno, A., Tanimichi, A., Nobeyama, A., Mori, M., et al . (2021) The 89-kDa PARP1 Cleavage Fragment Serves as a Cytoplasmic PAR Carrier to Induce AIF-Mediated Apoptosis. Journal of Biological Chemistry , 296, Article 100046. https://doi.org/10.1074/jbc.ra120.014479
Uetaki, M., Tabata, S., Nakasuka, F., Soga, T. and Tomita, M. (2015) Metabolomic Alterations in Human Cancer Cells by Vitamin C-Induced Oxidative Stress. Scientific Reports , 5, Article No. 13896. https://doi.org/10.1038/srep13896
Carr, A. and Frei, B. (1999) Does Vitamin C Act as a Pro‐Oxidant under Physiological Conditions? The FASEB Journal , 13, 1007-1024. https://doi.org/10.1096/fasebj.13.9.1007
Hoffer, L.J., Levine, M., Assouline, S., Melnychuk, D., Padayatty, S.J., Rosadiuk, K., et al . (2008) Phase I Clinical Trial of I.V. Ascorbic Acid in Advanced Malignancy. Annals of Oncology , 19, 1969-1974. https://doi.org/10.1093/annonc/mdn377